
The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo
Scialdone, Annarita, Hasni, Muhammad Sharif, Damm, Jesper Kofoed, Lennartsson, Andreas, Gullberg, Urban, Drott, KristinaVolume:
8
Langue:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.16964
Date:
June, 2017
Fichier:
PDF, 1.89 MB
english, 2017